Longer-Lived Implants for Longer-Lived People
Adenosine Treatment Could Cement Success of Implants
By Anette Breindl
Thursday, May 24, 2012
Researchers at the New York University School of Medicine have identified a treatment that they hope will extend the life expectancy of implants. In animal experiments, treatment with agonists of the adenosine 2A receptor prevented the inflammation and subsequent bone loss that is one of the leading causes of prosthesis loosening and implant failure.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.